CYCLODX recalled over out of specification test results
The notice says CYCLODX had out of specification test results, which it lists as a product quality issue.
What to do
Verify if your product is affected. Consult your healthcare provider before you stop using the affected product, or for any health concerns. Contact the recalling firm if you have questions about the recall.
Recall details
- Product
- CYCLODX
- Hazard
- Product quality
- Class or risk level
- Type III
- Notice last updated
- November 6, 2025
- Listed on Recalled Today
- November 6, 2025
Recalled Today dates each recall from the day it first appeared in the official data.
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from Health Canada.
CYCLODX: Out of Specification Test Results
- Product
- CYCLODX
- Issue
- Product quality
- What you should do
- Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
- Recall class
- Type III
- Category
- Radiopharmaceuticals
- Organization
- Drugs and health products
Contains information licensed under the Open Government Licence – Canada. Open Government Licence
Recalled Today is independent and is not an official government page.
Related recalls
Teva recalls Teva-Indomethacin over a product quality problem
Health Canada says Teva-Indomethacin is out of specification, which it lists as a product quality issue.
JAMP recalls Temozolomide over a product quality problem
The notice says JAMP Temozolomide is out of specification in an assay test, which it lists as a product quality issue.